A detailed history of Legal & General Group PLC transactions in Absci Corp stock. As of the latest transaction made, Legal & General Group PLC holds 8,341 shares of ABSI stock, worth $27,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,341
Previous 8,341 -0.0%
Holding current value
$27,775
Previous $31,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.92 - $6.58 $24,355 - $54,883
8,341 New
8,341 $25,000
Q2 2022

Aug 22, 2022

SELL
$3.13 - $8.83 $2,613 - $7,373
-835 Reduced 15.73%
4,473 $15,000
Q1 2022

May 16, 2022

BUY
$5.87 - $9.46 $23,521 - $37,906
4,007 Added 307.99%
5,308 $45,000
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $13,491 - $39,407
1,301 New
1,301 $15,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $309M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.